Tenenbaum Fabian
Insider CIK 1641300 · BLPH Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BLPH Bellerophon Therapeutics, | F Tax w/h | 2019-11-15 | 2019-11-19 | 76,823 | $0.34 | $26.1K | 407,459 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2019-09-26 | 2019-09-30 | 1,752,000 | — | $0 | 5,440,697 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2019-05-21 | 2019-05-22 | 5,000 | $0.60 | $3.0K | 484,282 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2019-01-02 | 2019-01-04 | 12,500 | — | $0 | 3,688,697 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2018-11-20 | 2018-11-23 | 1,487,500 | — | $0 | 3,676,197 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2018-09-25 | 2018-09-27 | 224,299 | — | $0 | 479,282 | SEC↗ |
| BLPH Bellerophon Therapeutics, | F Tax w/h | 2018-06-12 | 2018-06-14 | 63,486 | $2.37 | $150.5K | 254,983 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2018-01-12 | 2018-01-17 | 550,000 | — | $0 | 550,000 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2018-01-12 | 2018-01-17 | 55,419 | — | $0 | 318,469 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award | 2017-03-16 | 2017-03-20 | 120,193 | — | $0 | 263,050 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2016-12-07 | 2016-12-09 | 1,042,556 | — | $0 | 1,042,556 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy deriv | 2016-11-29 | 2016-12-01 | 142,857 | — | $0 | 142,857 | SEC↗ |
| BLPH Bellerophon Therapeutics, | P Buy | 2016-11-29 | 2016-12-01 | 142,857 | — | $0 | 142,857 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2016-11-11 | 2016-11-15 | 466,141 | — | $0 | 466,141 | SEC↗ |
| BLPH Bellerophon Therapeutics, | A Award deriv | 2016-02-29 | 2016-03-01 | 130,000 | — | $0 | 130,000 | SEC↗ |